Leadership

  • David Kass

    Principal, Leonard Green & Partners
  • Read Bio for Donald A. Deieso, PhD

    Donald A. Deieso, PhD

    Executive Chairman & Chief Executive Officer (CEO)
    full bio Read the bio for Donald A. Deieso, PhD

  • Eugene Gorbach, MBA

    Vice President, Arsenal Capital Partners

  • Henrik Kjær Hansen, MSc

    Senior Partner, Head of Principal Investments New Investments and Projects, Novo Holdings

  • Igor Baskin

    Vice President, GIC
  • Read Bio for James Rothman, PhD

    James Rothman, PhD

    Yale University; Recipient, Nobel Prize in Medicine, 2013
    full bio Read the bio for James Rothman, PhD

  • John Baumer, MBA

    Senior Partner, Leonard Green & Partners
  • photo of Dr. Kavita Patel

    Kavita Patel, MD

    Non-resident Fellow, Brookings Institution; Practicing Physician
  • photo of Pascale Witz

    Pascale Witz

    Former Executive Vice President, Sanofi; Former President and CEO of GE Healthcare Pharmaceutical Diagnostics

  • Peter Zippelius

    Partner, Leonard Green & Partners

  • Richard Ridinger

    Novo Advisory Group

  • Stephen McLean, MBA

    Senior Partner, Healthcare Group, Arsenal Capital Partners; Chairman, International Biomedical Research Alliance

  • Arthur L. Caplan, PhD

    Drs. William F. and Virginia Connolly Mitty Professor & Head, Division of Bioethics, New York University Langone Medical Center

  • Kenneth A. Getz, MBA

    FOUNDER AND CHAIRMAN, CISCRP; PROFESSOR, CENTER FOR THE STUDY OF DRUG DEVELOPMENT, TUFTS UNIVERSITY SCHOOL OF MEDICINE

  • Scott Hayworth, MD

    President & CEO, CareMount Medical; Senior Advisor and Advisory Board Member, Arsenal Capital Partners

  • Sir William Castell

    SENIOR ADVISOR, ARSENAL CAPITAL PARTNERS; PREVIOUSLY PRESIDENT & CHIEF EXECUTIVE OFFICER, GE HEALTHCARE

The WCG Oncology Advisory Board is made up of thought-leaders in oncology who provide WCG with guidance and strategic counsel on the changing landscape of research in oncology.

The WCG Gene Therapy Advisory Board provides guidance and strategic counsel to WCG and our clients, ensuring that knowledge and best practices are reflected in the company’s oversight of human gene transfer research, which involves the careful coordination of institutional review board (IRB) and institutional biosafety committee (IBC) reviews.

The CNS Scientific Leadership Team reflects multiple specialties within the therapeutic area of central nervous system (CNS). The specialists provide expert guidance to WCG’s clients, while also supporting the design and execution of WCG’s technology-enabled solutions applied to clinical trials in neurodegenerative and behavioral health disorders.